Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM‐Line): A two‐center open‐label pilot randomized controlled trial

by Rick Ikesaka, Deborah Siegal, Ranjeeta Mallick, Tzu‐Fei Wang, Deborah Witham, Carolyn Webb, Marc Carrier, for the Canadian Venous Thromboembolism Research Network (CanVECTOR)
Published 2021-05-01